|
Product complaint # (b)(4).Date sent to the fda: 7/30/2025.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.A manufacturing record evaluation was performed for the finished device lot, and no non-conformances were identified.Additional information was requested, the following was obtained: please describe the sterile packaging, are there any tears/holes in the sterile packaging? please refer to the returned device.Were there any issues with the seal of the sterile packaging? yes.H3 investigational summary: the product was returned to ethicon for evaluation.One unopened sample was received for analysis.Product code vcpb864d.During the initial inspection of the sample, a tear was observed in the foil packet.This damage appears to has been caused from the outside in by an unidentified object, compromising the sterility of the package.Due to the damage found on the device, the complaint is confirmed.The condition of the package is indicative of handling and storage issues that occurred outside of ethicon control.As part of the ethicon quality process, all devices are manufactured, inspected, and released to approved specifications.Additional complaint information monitoring for potential safety signals is conducted through complaint trending as part of post-market surveillance.
|